1. Home
  2. BNGO vs SYNX Comparison

BNGO vs SYNX Comparison

Compare BNGO & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • SYNX
  • Stock Information
  • Founded
  • BNGO 2003
  • SYNX 2005
  • Country
  • BNGO United States
  • SYNX Israel
  • Employees
  • BNGO N/A
  • SYNX N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • SYNX
  • Sector
  • BNGO Industrials
  • SYNX
  • Exchange
  • BNGO Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • BNGO 24.3M
  • SYNX 20.8M
  • IPO Year
  • BNGO 2018
  • SYNX 2024
  • Fundamental
  • Price
  • BNGO $5.36
  • SYNX $3.85
  • Analyst Decision
  • BNGO Hold
  • SYNX
  • Analyst Count
  • BNGO 3
  • SYNX 0
  • Target Price
  • BNGO $60.00
  • SYNX N/A
  • AVG Volume (30 Days)
  • BNGO 266.9K
  • SYNX 3.2K
  • Earning Date
  • BNGO 03-04-2025
  • SYNX 10-02-2024
  • Dividend Yield
  • BNGO N/A
  • SYNX N/A
  • EPS Growth
  • BNGO N/A
  • SYNX N/A
  • EPS
  • BNGO N/A
  • SYNX N/A
  • Revenue
  • BNGO $33,334,000.00
  • SYNX $9,893,000.00
  • Revenue This Year
  • BNGO N/A
  • SYNX $52.34
  • Revenue Next Year
  • BNGO $6.18
  • SYNX N/A
  • P/E Ratio
  • BNGO N/A
  • SYNX N/A
  • Revenue Growth
  • BNGO N/A
  • SYNX 18.05
  • 52 Week Low
  • BNGO $4.75
  • SYNX $2.10
  • 52 Week High
  • BNGO $81.00
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 34.06
  • SYNX 45.82
  • Support Level
  • BNGO $5.05
  • SYNX $3.60
  • Resistance Level
  • BNGO $6.32
  • SYNX $4.10
  • Average True Range (ATR)
  • BNGO 0.50
  • SYNX 0.26
  • MACD
  • BNGO 0.31
  • SYNX -0.04
  • Stochastic Oscillator
  • BNGO 38.85
  • SYNX 47.59

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: